Contact l Sitemap

home industries issues reasearch weblog press

Home  » Issues » Health

CorpWatch Exclusives

Actavis Sued To Stop Forced Switch To New Alzheimer's Drug
by Richard SmallteacherCorpWatch Blog
September 16th, 2014
Actavis, the world's third-largest generic drug manufacturer, has been sued by New York state to prevent it from forcing patients to take a new version of a popular Alzheimer's drug. The company is attempting to hook patients on an extended release version before its U.S. patent expires next year.

Gilead Sciences Under Investigation for Over Charging for Hepatitis C Pill
by Pratap ChatterjeeCorpWatch Blog
July 21st, 2014
Gilead Sciences of San Francisco is under investigation by the U.S. Senate Finance Committee for charging $84,000 for a 12 week course of a new drug to treat hepatitis C. Gilead sells the exact same course for $900 in poor countries like Egypt and India.

Big Pharma Abandons New Tuberculosis Drug Research
by Fatima HansiaCorpWatch Blog
April 1st, 2014
Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people.

New Zealand Dairy Exporter Admits Third Contamination Scandal
by Richard SmallteacherCorpWatch Blog
August 5th, 2013
Fonterra, a New Zealand company and the world’s largest dairy exporter, has apologized for exporting a milk formula ingredient contaminated with potentially toxic bacteria. The incident comes six years after a company subsidiary in China sold contaminated baby milk formula that killed six infants and made thousands more ill.

Myriad Loses Patent to Breast Cancer Genetic Test
by Richard SmallteacherCorpWatch Blog
June 13th, 2013
Myriad Genetics has lost its right to be the exclusive U.S. commercial provider of genetic screening tests for breast cancer or ovarian cancer. The American Civil Liberties Union (ACLU), which sued the company, claimed that the patent would limit scientific research as well as health care options for women.

Stanford Organics Study A “Fraud” – Linked to Cargill & Tobacco Money
by Pratap ChatterjeeCorpWatch Blog
September 13th, 2012
A new study, issued by scientists at the Freeman Spogli institute at Stanford university in California, that suggests that organic food has no medical or health values is deeply flawed, say outraged activists.

Big Tobacco Battles Advertising Restrictions
by Pratap ChatterjeeCorpWatch Blog
August 30th, 2012
Big Tobacco is fighting a multi-pronged battle to defeat a global wave of laws to force them to use graphic warning labels and plain packaging. It has won a major legal battle in the U.S. this month but it has lost in Australia.

Indian Supreme Court to Hear Novartis “Patents Versus Patients” Case
by Pratap ChatterjeeCorpWatch Blog
August 21st, 2012
Novartis, the Swiss pharmaceutical company, will appear before the Indian Supreme Court Wednesday to appeal against a patent rejection for a popular cancer drug. A decision in favor of the company could have a devastating impact on cheap supplies of many kinds of generic drugs for poor patients.

Hospital Corporation of America Allegedly Profited From Questionable Cardiac Procedures
by Pratap ChatterjeeCorpWatch Blog
August 7th, 2012
Hospital Corporation of America (HCA) – the world’s largest operator of private clinics and hospitals – has come under the spotlight for performing unnecessary cardiac procedures, notably in Florida.

Fighting Malaria: Big Pharma or Better Aid Coordination?
by Pratap ChatterjeeCorpWatch Blog
May 2nd, 2012
Why don’t drug companies invest enough money in treating malaria and tuberculosis? A recent study published in the Lancet magazine estimates that 1,238,000 people died from malaria in 2010. Surely a wonder drug that stops these diseases would be wildly profitable?

Grey Market Drugs: Profiting from Poorly Managed U.S. Health Care
by Terry J. AllenSpecial to CorpWatch
January 22nd, 2012
Scalpers are doing a booming business in key medical drugs by taking advantage of U.S. patients and hospitals when they are desperate for supplies from the poorly regulated $46 billion global contract-manufacturing industry.

Asia Inhales While the West Bans the Deadly Carcinogen
by Melody KempSpecial to CorpWatch
February 16th, 2010
Asbestos, a known carcinogen, causes 100,000 occupational deaths per year. Although banned in much of the world, asbestos is a common and dangerous building block in much of Asia’s development boom, and its export remains both legal and profitable -- to the health detriment of the region.

The Enbridge Oil Sands Gamble
by Andrew NikiforukSpecial to CorpWatch
December 14th, 2009
Patrick Daniel, the CEO of Enbridge Inc, is bullish about the future of unconventional oil from Canada’s massive tar sand deposits. His company not only operates North America’s longest crude oil and liquid pipelines, but transports 12 percent of the oil that the U.S. imports daily. Canada’s bitumen, or dirty crude, lies under a forest area the size of England and is arguably the world’s last remaining giant oil field.

Bhopal: Generations of Poison
by Nityanand JayaramanSpecial to CorpWatch
December 2nd, 2009
On the night of December 2-3, 1984, the Union Carbide pesticide factory in Bhopal, India leaked poisonous methyl iso cyanate into its densely populated neighborhood, killing 8,000 people in the immediate aftermath. 25 years later, Dow Chemical (which purchased Union Carbide in 2001) still refuses to clean up the site. But a new generation of Bhopal survivors is taking on the fight.

Uranium Corporation of India Limited: Wasting Away Tribal Lands
by Moushumi BasuSpecial to CorpWatch
October 7th, 2009
In Eastern India's Jharkand State, tensions are mounting between Indigenous tribal communities and the Uranium Corporation of India Limited, or UCIL. Heavy security at a May public hearing in Jadugoda prevented many local activists and villagers from entering. But outside the hearing, activists from the Jharkhandi Organization Against Radiation (JOAR) argued their case for protecting their health and the environment from horrific impacts of radioactive contaminated waste resulting from uranium mining.

Damming Magdalena: Emgesa Threatens Colombian Communities
by Jonathan LunaSpecial to CorpWatch
July 21st, 2009
Near the town of La Jagua, overlooking the Magdalena River, the landscape is dotted with concrete markers declaring the land, river, and everything else a “public utility” that Colombia has given to the energy company Emgesa as part of the Quimbo Hydroelectric Project. A construction permit was granted in May, with the dam scheduled for full operation by 2014.

The True Cost of Chevron: An Alternative Annual Report
by Antonia Juhaszhttp://www.TrueCostofChevron.com/
May 26th, 2009
Chevron's 2008 annual report is a glossy celebration of the company's most profitable year in its history. What Chevron's annual report does not tell its shareholders is the true cost paid for those financial returns, or the global movement gaining voice and strength against the company's abuses. This jointly-produced report documents negative impacts of Chevron's operations around the globe, in stark contrast to the message sent by the company's ubiquitous "Human Energy" advertising campaign.

Goa Cursed By Its Mineral Wealth
by Emily BildSpecial to CorpWatch
April 23rd, 2009
Set on India's west coast, Goa is renowned as a beach paradise popular with Indian and foreign tourists alike. Just a few miles inland from the quaint restaurants and the pristine waves lapping the silver shores of India's smallest state, iron-ore mining is destroying the environment, say activists and locals.

Ducking Responsibility: Entergy Spins Its Nukes
by Shay TottenSpecial to CorpWatch
August 4th, 2008
Entergy Nuclear (part of the broader Entergy energy family) is spinning off its northeastern U.S.-based nuclear power plants into a related limited liability corporation, Enexus. Stakeholders in Vermont, home of the Yankee Nuclear power plant, are less than happy, with Entergy also reneging on prior commitments to cover eventual plant decommissioning costs, potentially stranding taxpayers with much of the bill.

Crossing the Wayúu: Pipeline Divides Indigenous Lands in South America
by Jonathan Luna Special to CorpWatch
June 5th, 2008
Touted as the first step in a major regional integration project, the 225-kilometer TransCaribe pipeline travels underground across Colombia's Guajira Peninsula to the gas refineries of Maracaibo, Venezuela. Protesting the mega project's impacts on the peninsula's indigenous communities, the Wayúu community of Mashiis-Manaa is leading the struggle against oil giant Petróleos de Venezuela.

Displaying 1-20 of 44  
Next >> 
Last Page » 
« Show Complete List »